IL10 and autoimmune disease: Recent studies showed that the increase of IL-10-producing Foxp3+Tregs was accompanied with disease remission in several different systematic autoimmune diseases, such as experimental autoimmune encephalomyelitis, diabetes, and arthritis [28–30].